Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,082.00
Bid: 12,080.00
Ask: 12,084.00
Change: -74.00 (-0.61%)
Spread: 4.00 (0.033%)
Open: 12,092.00
High: 12,098.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks higher as focus shifts towards Greece

Thu, 19th Mar 2015 17:30

UK equities registered slight gains as traders digested the policy announcement issued by the US Federal Reserve overnight and despite the renewed tensions evident in Greek funding markets.The Footsie ended the day 17 points higher at 6,962.32, with some effects from Wednesday's Budget from Chancellor George Osborne also still filtering through.As expected, the US central bank yesterday omitted any reference to being "patient" when starting to tighten interest rates, but the 17 members of the Federal Open Market Committee nearly halved their median projection for the level of the Fed funds rate at year-end 2015 to 0.625%.Investors were increasingly focusing on Thursday's summit of European Union heads of government and the news-flow surrounding the negotiations with Greece.The yield on the benchmark 10-year Greek government bond sprinted 104 basis points higher to 12.14%.That was despite reports earlier in the day that the European Central Bank had opposed forbidding Greek lenders from purchasing short-term government securities.Some market reports cited sources according to whom the daily outflows of Greek deposits had reached one-month highs.Against analysts' predictions Norway's central bank maintained its deposit rate at 1.25%, instead of reducing it by 25 basis points. Nonetheless, the monetary authority clearly signalled that it will soon be lowering its key rate further, analysts at Capital Economics said.Earlier in the day Switzerland's central bank, the SNB, kept its target range for the three-month Libor unchanged, at between -1.25% and -0.25%, as expected. However, the SNB cautioned that it could cut rates further or intervene in foreign exchange markets, if necessary, to curb strength in the swiss franc's value.Next drops after full-year profits UK clothing retailerNext grew its underlying pre-tax profit by 12.5% last year as overall sales rose by 7.2%. The company said its share buyback scheme meant that underlying EPS grew by 14.7% and dividends for the full year will increase by 16.3%, to 150p.Auto Trader Group, the UK car classified ad company on Thursday priced 590m shares at 235p/share in its initial public offering in the London market. The company is raising £437m of net proceeds in the offer with its private equity owner, Apax expected to raise around £926.2m out of the flotation. As of 12:18 the shares were changing hands at 268.75p.Chip designer ARM Holdings's market share in servers may reach 20% by 2020, versus less than 1% at present, the company has reportedly said. The London-listed outfit was scheduled to make a presentation at today's Bank of America Merrill Lynch Technology & Beyond Conference, in Taiwan.Electronics components distributor Premier Farnell reported adjusted profits before tax down 3% to reach £74m in 2014 but maintained its full-year dividend pay-out at 10.4p. That came on the back of a 0.8% fall in full-year revenues to £960.1m. However, the company's operating margins declined by less than forecast by analysts, slipping by 40 basis points, to 9.2%. The analyst consensus was for margins of 9%. Earnings per share (EPS) on an adjusted basis came in at 13.8p, down 3.5% from the prior year but ahead of the 13.5p which analysts had pencilled in.AstraZeneca has signed an agreement with Japanese-headquartered company Daiichi Sankyo to jointly commercialise a new drug called Movantik, an oral treatment for opioid-induced constipation in adults with chronic non-cancer pain. No longer labelled a controlled substance by the US Drug Enforcement Administration, its launch has been scheduled to take place early in April 2015.Savills reported a 21% increase in pre-tax profit to £84.7m, as revenue rose 19% to £1.08bn driven by a 38% increase in transaction advisory revenue, which the company attributed to the performance of the Savills Studley business in the US, strong performances in Asia and the UK and recovery in some European markets.Market MoverstechMARK 3,254.47 +0.15%FTSE 100 6,962.32 +0.25%FTSE 250 17,438.15 +0.43%FTSE 100 - RisersFresnillo (FRES) 679.00p +5.43%Randgold Resources Ltd. (RRS) 4,826.00p +3.23%Marks & Spencer Group (MKS) 531.50p +3.10%Tullow Oil (TLW) 309.60p +2.25%Antofagasta (ANTO) 695.00p +1.98%Aviva (AV.) 566.00p +1.89%BHP Billiton (BLT) 1,485.50p +1.89%Kingfisher (KGF) 374.40p +1.88%Friends Life Group Limited (FLG) 432.10p +1.86%GKN (GKN) 375.10p +1.74%FTSE 100 - FallersNext (NXT) 7,315.00p -4.00%British American Tobacco (BATS) 3,668.00p -3.37%TUI AG Reg Shs (DI) (TUI) 1,181.00p -2.24%Anglo American (AAL) 1,046.00p -2.20%Meggitt (MGGT) 577.50p -1.70%Imperial Tobacco Group (IMT) 3,155.00p -1.44%Hargreaves Lansdown (HL.) 1,189.00p -1.41%Admiral Group (ADM) 1,518.00p -1.24%St James's Place (STJ) 966.50p -1.18%CRH (CRH) 1,751.00p -1.13%FTSE 250 - RisersSoco International (SIA) 160.10p +8.25%Premier Oil (PMO) 146.70p +8.03%Indivior (INDV) 201.90p +5.98%Acacia Mining (ACA) 248.00p +5.58%Afren (AFR) 3.31p +5.28%Supergroup (SGP) 918.50p +5.15%Renishaw (RSW) 2,588.00p +4.65%Centamin (DI) (CEY) 53.70p +4.07%Evraz (EVR) 195.20p +3.77%Crest Nicholson Holdings (CRST) 441.00p +3.72%FTSE 250 - FallersBrit (BRIT) 278.50p -8.60%Lancashire Holdings Limited (LRE) 632.50p -6.92%Hiscox Ltd (CDI) (HSX) 805.00p -5.07%Jupiter Fund Management (JUP) 412.80p -3.12%Jimmy Choo (CHOO) 170.00p -2.86%Ted Baker (TED) 2,746.00p -2.52%Serco Group (SRP) 170.60p -2.29%FirstGroup (FGP) 92.95p -2.05%Ladbrokes (LAD) 111.20p -2.03%Jardine Lloyd Thompson Group (JLT) 1,049.00p -1.96%
More News
Today 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.